Advertisements

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Trastuzumab

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Trastuzumab.....»»

Category: press-releasesSource: businesswireindiaJan 11th, 2017

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Pegfilgrastim for Review

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Pegfilgrastim for Review.....»»

Category: press-releasesSource: businesswireindiaFeb 16th, 2017

EMA accepts Biocon, Mylan biosimilar for review

EMA accepts Biocon, Mylan biosimilar for review.....»»

Category: topSource: the-hinduAug 25th, 2016

Biocon in focus as breast cancer biosimilar gets US FDA advisory panel’s endorsement

Biocon in focus as breast cancer biosimilar gets US FDA advisory panel’s endorsement.....»»

Category: topSource: moneycontrolJul 13th, 2017

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data.....»»

Category: press-releasesSource: businesswireindiaDec 27th, 2016

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data.....»»

Category: press-releasesSource: businesswireindiaDec 27th, 2016

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data.....»»

Category: press-releasesSource: businesswireindiaDec 27th, 2016

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data.....»»

Category: press-releasesSource: businesswireindiaDec 27th, 2016

Mylan-Biocon seek USFDA nod for biosimilar version of cancer drug

Mylan-Biocon seek USFDA nod for biosimilar version of cancer drug.....»»

Category: featuresSource: livemintNov 9th, 2016

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab.....»»

Category: press-releasesSource: businesswireindiaNov 8th, 2016

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab.....»»

Category: press-releasesSource: businesswireindiaNov 8th, 2016

Trastuzumab marketing approval may come in 12-18 months: Biocon

Trastuzumab marketing approval may come in 12-18 months: Biocon.....»»

Category: topSource: moneycontrolAug 26th, 2016

EMA accepts Mylan, Biocon Trastuzumab biosimilar for review

EMA accepts Mylan, Biocon Trastuzumab biosimilar for review.....»»

Category: topSource: moneycontrolAug 25th, 2016

Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency

Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency.....»»

Category: press-releasesSource: businesswireindiaAug 25th, 2016

Mylan, Biocon report efficacy of cancer drug

Mylan, Biocon report efficacy of cancer drug.....»»

Category: topSource: the-hinduJun 5th, 2016

Mylan, Biocon confirm efficacy of trastuzumab biosimilar

Mylan, Biocon confirm efficacy of trastuzumab biosimilar.....»»

Category: topSource: moneycontrolJun 4th, 2016

Biocon withdraws application for EU approval of two biosimilar drugs

Biocon withdraws application for EU approval of two biosimilar drugs.....»»

Category: featuresSource: livemint21 hr. 21 min. ago

Biocon cancer drug now only a step away from getting USFDA approval

Biocon cancer drug now only a step away from getting USFDA approval.....»»

Category: featuresSource: business-standardJul 14th, 2017

USFDA recommends approval of Biocon"s breast cancer biosimilar - Livemint

USFDA recommends approval of Biocon"s breast cancer biosimilar - Livemint.....»»

Category: topSource: googlenewsJul 14th, 2017

USFDA recommends approval of Biocon’s breast cancer biosimilar

USFDA recommends approval of Biocon’s breast cancer biosimilar.....»»

Category: featuresSource: livemintJul 14th, 2017

Biocon"s Breast Cancer Biosimilar Gets USFDA Panel Nod, Shares Surge - NDTV

Biocon"s Breast Cancer Biosimilar Gets USFDA Panel Nod, Shares Surge - NDTV.....»»

Category: topSource: googlenewsJul 14th, 2017